When iodine is used as a drug in Britain, we’re all at risk
A new report from the Institute for Social Policy and Research (ISPR) has highlighted the potential dangers of iodine as a pharmaceutical drug, saying it’s increasingly being used as an anti-inflammatory.
The report is titled The End of Iron?, which was published on Tuesday and focuses on the role that iodine can play in the treatment of conditions such as osteoarthritis, inflammatory bowel disease (IBD), inflammatory arthritis and the common cold.
It’s been suggested that it could help prevent and treat some of the most common infections, such as MRSA, pneumonia and influenza, and has been used in conjunction with other medications.
It is not, however, known if there are any known side effects, such a stomach ache or dizziness, or whether it can be toxic to humans.
ISPR is a think tank based in the UK that has long warned about the dangers of over-medicating the NHS.
It published an analysis last year showing that some antibiotics could be fatal in high doses, and that iodine could potentially cause cancer.
In the UK, there are currently two types of iodine, iodine-131 and iodine-137.
The first is a chemical that’s found in the earth and in the water, which is a mixture of isotopes.
It has a molecular weight of 2,867, and the second is the more stable, less toxic form.
The new study looked at the use of iodine-127 in the NHS in the United Kingdom, and concluded that the use has increased from 3.3% of the total drug prescriptions in 2009 to 13.9% in 2015.
The iodine-129, or iodine-138, is a form of iodine that is not a chemical and is found in seawater, which makes it less harmful to the body than the isotopes, which are in the soil.
The researchers looked at a range of drug applications, from chemotherapy and surgery to antibiotics and blood thinners.
The main finding was that people with anemia, who were given antibiotics for a long period of time, were more likely to develop severe, chronic illness and death from cancer, as well as having a higher mortality rate.
The study also found that iodine-135, which has a lower molecular weight, was associated with an increased risk of mortality.
It also found a link between iodine-134 and the more common cold, the common acute respiratory syndrome, or CAS.
The authors said there was a potential increase in the use and distribution of iodine in the world, with the amount of iodine consumed by the public rising by 60% between 1999 and 2011.
“The potential for adverse effects in use of iodized salt, such that patients experience adverse effects as a result of ingestion of the isotopic iodine, raises concern about the potential risks of the use,” the report read.
The research has been published in the British Journal of Nutrition.
It was led by Dr Stephen J. Hall, from the Department of Medicine, University of Cambridge.
He said: “It’s very clear that iodine is an important component of the human body, and we need to understand the underlying mechanisms that lead to its use in medicine.”
The use of isotopic salts has been linked to several clinical outcomes, including the use as a medication in the management of inflammatory conditions and osteoarsis, and also in the prevention of COVID-19, and is now being considered for use as an alternative to aspirin for the treatment and prevention of cancer.
“While the potential benefits of the therapeutic use of this chemical are unknown, the increased use of it is a concern that needs to be considered.”
Dr Hall added that there is a need to “make sure that people are getting the right doses of iodine for their specific circumstances”.
“We have to look at the safety of iodine supplementation to ensure that people get the correct amount of this nutrient, and to ensure the health benefits of it,” he said.
The ISPR report was published in a special issue of the journal BMJ, in collaboration with the Institute of Medicine.
The scientists analysed data from the NHS’s drugs, services and health records and found that from 2010 to 2015, the total amount of iodised salt in the country increased by more than two-thirds.
This is an increase of 6,000 tonnes, or about 10% of all the drugs and medicines administered in the nation.
Dr Hall said: It’s important to remember that the majority of the iodine used by the NHS is for anti-inflammation, and not as a cure.
“Iodine is a compound with the highest molecular weight in the whole of the earth, and it’s also an element of a number of naturally occurring compounds in the body, including iodine, zinc, manganese and copper,” he explained.
“So if you have any problems with the concentration of iodine you need to supplement that with the proper amounts of the other minerals and other compounds.”
The study, which looked at more than 1.2 million prescriptions of iodine tablets